🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Florida › Miami

Qorannoo klinikaalii Myelodysplastic Syndromes Miami, FL keessatti

Qorannoo 17 Myelodysplastic Syndromes f Miami fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sylvester Cancer Center - U Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07422480

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06566742

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • University of Miami Hospital and Clinics, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06499285

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC), Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04419649

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

Namoota walitti qabaa jira
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07469592

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05308264

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Miami, Miami
  • Miami Cancer Institute, Miami
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Namoota walitti qabaa jira
  • Sylvester Comprehensive Cancer Center, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Gur-2026 · NCT05745285

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Namoota walitti qabaa jiraSadarkaa 1
  • University of Miami Health System, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ama-2026 · NCT05143996

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Mud-2025 · NCT04245397

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Miami
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • Sylvester Comprehensive Cancer Center, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT06501196

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Miami keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.